Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Completes Acquisition of BioSystem Development

NEW YORK (GenomeWeb News) – Agilent Technologies today said that it has completed the acquisition of BioSystem Development for an undisclosed sum.

The firm announced earlier this month that it would acquire the privately held maker of the AssayMAP microchromatography platform.

BioSystem Development, based in Madison, Wis., currently supplies Agilent's Automation Solutions business with AssayMap cartridges that are used with Agilent's Bravo liquid handling platform for protein purification and characterization workflows.

The agreement was announced at the same time Agilent said it had acquired next-generation sequencing sample preparation firm Halo Genomics, formerly known as Olink Genomics.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.